Please provide your email address to receive an email when new articles are posted on . Medtronic announced a global voluntary recall of unused thoracic stent graft systems and notified physicians to ...
Medtronic Inc. (NYSE: MDT) has made the first enrollment in a U.S. clinical trial testing the use of a stent graft in patients with a potentially life-threatening cardiovascular condition. The ...
Medtronic is recalling its Valiant Navion thoracic stent graft system after discovering three patients in a clinical trial had stent fractures and one patient death was reported, the medical ...
New Clinical Data from PANDORA and ENGAGE Affirm Market-Leading Medical Device's Durable, Consistent and Proven Outcomes In Endovascular Treatment of Abdominal Aortic Aneurysms MINNEAPOLIS --The ...
Indicated for Endovascular Treatment of Abdominal Aortic Aneurysms, Medical Device Has Been Used to Treat More Than 6,000 Patients in United States Since December FDA Approval MINNEAPOLIS--(BUSINESS ...
Enhanced Medical Device to Repair Abdominal Aortic Aneurysms Without Open Surgery Expands Physicians’ Options for Treating ‘Silent Killer’ MINNEAPOLIS –– Medtronic Inc. today announced the CE ...
MINNEAPOLIS--(BUSINESS WIRE)-- Further demonstrating its commitment to proving the benefits of minimally-invasive procedures, Medtronic, Inc. (NYSE: MDT), today announced that the first patient has ...
(RTTNews) - Medtronic plc has recalled unused Medtronic Valiant Navion thoracic stent graft system globally, according to the U.S. Food and Drug Administration. The Irish medical technology company ...
DUBLIN, Oct. 08, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its Valiant® ...
Patients also had an extremely low rate of stent graft leakage, and a majority of patients (62%) saw their aneurysms decline at least 5 mm in size. Similarly, 98% of the 500 patients who took part in ...
DUBLIN, Feb. 17, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, has voluntarily issued a global recall of unused Medtronic Valiant Navion™ thoracic stent graft ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results